Benitec Biopharma Inc.
BNTC· Nasdaq
BNTCBenitec Biopharma Inc.
Quarterly figures for Benitec Biopharma Inc., with source filings when available.
28 quarters. Sep 30, 2019 to Jun 30, 2026. USD.
Benitec Biopharma Inc. has filed its 10-Q within 43 to 45 days of period end across its last 8 quarters. The 10-K runs 64 to 88 days.
Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q4 2026derived | Jun 30, 2026 | Sep 14, 2026 · after-hours | Sep 14, 2026 | 76 d | 10-K | — | — | — | |
| Mar 31, 2026 |
| May 14, 2026 · pre-market |
| May 14, 2026 |
| 44 d |
| 10-Q |
| $0.00 |
| — |
| -$0.24 |
| Q2 2026 | Dec 31, 2025 | Feb 12, 2026 · pre-market | Feb 12, 2026 | 43 d | 10-Q | $0.00 | — | -$0.26 |
|---|
| Q1 2026 | Sep 30, 2025 | Nov 14, 2025 · after-hours | Nov 14, 2025 | 45 d | 10-Q | $0.00 | — | -$0.22 |
|---|
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | Jun 30, 2025 | Sep 22, 2025 · after-hours | Sep 22, 2025 | 84 d | 10-K | — | — | -$0.21 | |
| Q3 2025 | Mar 31, 2025 | May 14, 2025 · pre-market | May 14, 2025 | 44 d | 10-Q | $0.00 | — | -$0.38 | |
| Q2 2025 | Dec 31, 2024 | Feb 14, 2025 · pre-market | Feb 14, 2025 | 45 d | 10-Q | $0.00 | — | -$0.33 | |
| Q1 2025 | Sep 30, 2024 | Nov 14, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | $0.00 | — | -$0.18 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Jun 30, 2024 | Sep 26, 2024 · after-hours | Sep 26, 2024 | 88 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2024 | Mar 31, 2024 | May 13, 2024 · pre-market | May 13, 2024 | 43 d | 10-Q | $0.00 | −100.0% | -$0.23 | |
| Q2 2024 | Dec 31, 2023 | Feb 13, 2024 · pre-market | Feb 13, 2024 | 44 d | 10-Q | $0.00 | −100.0% | -$2.64 | |
| Q1 2024 | Sep 30, 2023 | Nov 13, 2023 · pre-market | Nov 13, 2023 | 44 d | 10-Q | $0.00 | — | -$3.05 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Jun 30, 2023 | Sep 21, 2023 · pre-market | Sep 21, 2023 | 83 d | 10-K | $7.00K | — | — | |
| Q3 2023 | Mar 31, 2023 | May 15, 2023 · pre-market | May 15, 2023 | 45 d | 10-Q | $54.00K | +12.5% | -$2.67 | |
| Q2 2023 | Dec 31, 2022 | Feb 13, 2023 · pre-market | Feb 13, 2023 | 44 d | 10-Q | $14.00K | −44.0% | -$3.34 | |
| Q1 2023 | Sep 30, 2022 | Nov 10, 2022 · pre-market | Nov 10, 2022 | 41 d | 10-Q | $0.00 | — | -$7.98 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Jun 30, 2022 | Sep 2, 2022 · pre-market | Sep 2, 2022 | 64 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2022 | Mar 31, 2022 | May 16, 2022 · pre-market | May 16, 2022 | 46 d | 10-Q | $48.00K | +4,700.0% | -$0.40 | |
| Q2 2022 | Dec 31, 2021 | Feb 14, 2022 · pre-market | Feb 14, 2022 | 45 d | 10-Q | $25.00K | +2,400.0% | -$0.59 | |
| Q1 2022 | Sep 30, 2021 | Nov 15, 2021 · pre-market | Nov 15, 2021 | 46 d | 10-Q | $0.00 | −100.0% | -$0.62 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Jun 30, 2021 | Sep 20, 2021 · pre-market | Sep 20, 2021 | 82 d | 10-K | $2.00K | — | — | |
| Q3 2021 | Mar 31, 2021 | — | May 12, 2021 | 42 d | 10-Q | $1.00K | −96.4% | -$0.82 | |
| Q2 2021 | Dec 31, 2020 | — | Feb 9, 2021 | 40 d | 10-Q | $1.00K | −98.7% | -$0.76 | |
| Q1 2021 | Sep 30, 2020 | — | Nov 13, 2020 | 44 d | 10-Q | $55.00K | +66.7% | -$2.45 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Jun 30, 2020 | Sep 23, 2020 · after-hours | Sep 23, 2020 | 85 d | 10-K | — | — | — | |
| Q3 2020 | Mar 31, 2020 | — | — | — | — | $28.00K | — | -$1.96 | |
| Q2 2020 | Dec 31, 2019 | — | — | — | — | $77.00K | — | -$2.00 | |
| Q1 2020 | Sep 30, 2019 | — | — | — | — | $33.00K | — | -$1.34 | |
